Improving the Quality of Care at the Point of Care
g-Nostics Ltd was founded to commercialise innovative technology in the pharmacogenetic sector. Using a simple finger-prick test we identify each persons unique molecular profile and then use the information to predict individual response to drug therapy. This pharmacogenetic technology can identify the best treatment with lowest risk of side effects in a wide range of medical conditions. Open Letter: Life Science - Save CGT Relief.Read more... Survey... Petition... |
|
Read more...
|
|
NicoTest™ is a diagnostic procedure that establishes the preferred treatment for smoking cessation based on individual molecular profile. NicoTest™ is a simple and safe procedure carried out in much the same way as a test for blood sugar. Visit the NicoTest website here . Supporting References for NicoTest™ here . 
NicAlert™ is the ONLY accurate, CE Marked, Point of Care test for use by Healthcare Professionals to identify and distinguish between smokers and non-smokers. NicAlert™ is a simple point of care diagnostic test that is a fast, inexpensive and easy to use disposable test strip. Visit the NicAlert website here . |
|
Read more...
|
|
Study to assess the effectiveness and cost-effectiveness of the NicoTest™ programme. The purpose of the study is to evaluate the relative outcomes (quit rate) and costs (cost per quitter) of NicoTest™ compared to the present NHS best practice treatment regime at the 1 month post-quit date, 3 month time point, 6 month time point and 12 month time point. |
|
Read more...
|
|
|
